A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has removed problematic material and banned associated hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing compliance measures.
Digital Trading Operations
Research also found communities with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.
After moments of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Details and Pricing
Inside these groups, posts show black plastic packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly serious medical dangers”.
